Methocel Direct Compression (DC) premium grade hypromellose polymers can reduce the costs of manufacturing pharmaceutical tablets by enabling processes that eliminate the wet granulation step. The polymers exhibit improved powder flow properties by virtue of their specially engineered particle morphology and size distribution. The result is the ability to carry out direct compression of tablets without the need for wet granulation. Methocel DC polymers offer comparable performance with regard to drug formulation attributes, including tablet hardness and controlled release drug action, to equivalent Methocel products. The new excipient also holds the same regulatory status as existing related excipient polymers. — Dow Wolff Cellulosics, Horgen, Switzerland
This excipient reduces tablet manufacturing costs
| By Chemical Engineering